Member Info for Pie-chart

On CNBC's Squawk Box, Primetime Partners' Abby Levy explains what makes the longevity sector a good play for investors:

"What makes for a good investment in this space is recognizing that the population is going to double in size in terms of those aged 65 and older. Within that there becomes a whole slew of services that will be required to help us age more successfully."

GenFlow Biosciences (LON:GENF) (OTCQB:GENFF) is an early player in the field of Biotech, dedicated to the development and commercialization of novel therapeutics that target ageing. Through these efforts, we aim to decrease healthcare costs and alleviate the emotional and societal burden that comes with an ageing population.

https://loom.ly/D6xz3Ig

THIS IS VERY PROMISING!!!

On CNBC's Squawk Box, Primetime Partners' Abby Levy explains what makes the longevity sector a good play for investors:

"What makes for a good investment in this space is recognizing that the population is going to double in size in terms of those aged 65 and older. Within that there becomes a whole slew of services that will be required to help us age more successfully."

GenFlow Biosciences (LON:GENF) (OTCQB:GENFF) is an early player in the field of Biotech, dedicated to the development and commercialization of novel therapeutics that target ageing. Through these efforts, we aim to decrease healthcare costs and alleviate the emotional and societal burden that comes with an ageing population.

https://loom.ly/D6xz3Ig

New article from Genflow:

Did you know that our DNA, the blueprint of who we are, can face natural damage as we age? DNA damage isn't just about looks; it affects our health too, and can lead to conditions like cancer, arthritis and heart issues.

At GenFlow Biosciences (LON:GENF)(OTCQB:GENFF), we’re committed to repairing DNA damage and increasing healthspan with the help of our friends, sirtuins. Sirtuins work in your body to delay cellular senescence by maintaining the protective telomeres on chromosomes, sustaining genome integrity, and promoting DNA damage repair.

Read all about our mission here: https://loom.ly/jafdDic

GenFlow Biosciences (LON:GENF) (OTCQB:GENFF) aims to enhance healthy aging by introducing additional copies of a centenarian variant of the Human SIRT6 gene through an ethical, safe, and efficient gene delivery mechanism.

The pursuit of longer, healthier lives is driving an incredible wave of innovation, with the global longevity market set to reach $44.2B by 2030.

Technological advancements are reshaping our approach to health, heralding a new era of vitality. Breakthroughs in cellular rejuvenation, gene editing, and AI-driven therapies are making waves.

Read more about it here: https://loom.ly/HSiu9PE

In case you don't notice.......this conference is in New York.

When this catches on in the US you can say goodbye to sub 10p

GenFlow Biosciences (LON:GENF)(OTCQB:GENFF) is dedicated to improving health through the development of medications with the potential to halt or slow the aging process. Join our CEO Eric Leire at Lifespan.io (Lifespan Extension Advocacy Foundation)'s sixth annual Ending Age-Related Diseases (EARD) conference August 10-11.

https://www.lifespan.io/ending-age-related-diseases-2023/#:~:text=On%20August%2010%2D11%2C%202023,researchers%2C%20and%20government%20organizations%20together

Everyone who sold last week scrambling back in..lol.

Fully locked and loaded. This price will never be seen again! Fill up if you can!

Such a shame for these impatient people. There is no reason to sell at this stage.

News will be soon. I'd hate to be the person that sells today and cries tomorrow.

There's actually plenty to talk about. Most of which can only be disclosed when the time is right. However, that time is soon. I expect a flurry of good news once the seal breaks.

There is absolutely no doubt where this is going before the month is out.

Anyone waiting for a better entry point will miss this like a freight train if they wait too long. We can just reflect on pervious 'new highs' to see how much buyers are sitting waiting to pounce and send this up past ATH.